Our In-vivo pharmacology studies disease models in animals and in- vivo assays are designed to replicate human disease in animals across various therapeutic areas which can be tailored as per protocols designed by the client or regulatory body. Our in-vivo pharmacology team consists of highly experienced scientists with extensive drug discovery backgrounds. In-vivo pharmacology studies team is experienced in +1000 efficacy studies, with study data submissions to the US FDA & DCGI. We have the capability to handle 600 rodents at a given time.
Submissions to the US FDA and DCGI
Highly Qualified and Experienced Scientists
Capacity to handle more than 600 rodents at a given time